EWALL-PH OBSERVARTORY 2022
ConditionAcute Lymphoblastic Leukemia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorVersailles Hospital
About this trial
An observatory for patients aged 18 years and over with Philadelphia chromosome positive (Ph+ or BCR::ABL1) acute lymphoblastic leukemia (ALL) and treated with the combination of BCR::ABL1 inhibitors and chemotherapy and/or corticosteroids and/or a monoclonal antibody.
Eligibility criteria
Qualifiers
Male or female patients ≥ 18 years
Philadelphia chromosome or BCR::ABL1 positive acute lymphoblastic leukaemia
Treatment with the combination of BCR::ABL1 inhibitors and chemotherapy and/or corticotherapy and/or a monoclonal antibody
Disqualifiers
Patients deceded and having previously refused data collection
Not included in a prospective clinical trial
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov